And if you had backed the TLX story as highlighted in the thread title and content of your post you would be sitting on handsome share price appreciation from $1.78 to $4.73. In the same period SPL has sunk from $1.24 to 62 cents.
The old Starpharma ‘has many irons in the fire’ and ‘optionality’ has gone well past it’s use-by date.
The stale Chairman and CEO need to go.
Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform, page-5
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |